Sun 5/19/2013 22:07 ET DJIA 15354.40 122.84 0.80% SOLAR 23.63 1.24 5.26% GOLD 1356.30 30.60 2.21% Shanghai 2284.85 2.06 0.09% S&P 500 1667.47 17.17 1.03% BANKS 19.95 0.26 1.32% OIL 96.03 0.87 0.91% Nikkei 15308.49 172.99 1.13% NASDAQ 3498.97 33.94 0.97% SEMI 38.77 0.43 1.12% US/EU 0.78 0.00 0.39% Futures 1664.20 1.20 0.07%

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search    From: Lady_Renegade (Rep: 24) Date: 01/25/2012 18:57 Forum: Wall Street Pit - Msg #2229742 Thread #673351013 (Rec: 0) Pending FDA Drug Approval Decisions: Jan. 27: Amylin Pharmaceuticals'(AMLN_) Bydureon for diabetes. Feb. 14: BioSante Pharmaceuticals'(BPAX_) Bio-T-Gel for hypogonadism. Feb. 17: Corcept Therapeutics'(CORT_) Corlux for Cushing's sydrome. Feb. 26: Columbia Labs'(CBRX_) Prochieve for reduction of risk of preterm birth. March 6: Discovery Labs'(DSCO_) Surfaxin for respiratory distress syndrome. March 6: Astex Pharmaceuticals'(ASTX_) Dacogen for acute myeloid leukemia. March 7: Neurogesx'(NGSX_) Qutenza for HIV-related nerve pain. March 8: Roche and Curis'(CRIS_) vismodegib for basal cell carcinoma. March 26: MAP Pharmaceuticals'(MAPP_) Levadex for migraines. March 27: Affymax's(AFFY_) peginesatide for anemia due to chronic kidney disease. March 28: Chelsea Therapeutics'(CHTP_) Northera for orthostatic hypotension. April 17: Vivus'(VVUS_) Qnexa for obesity. April 18: Vertex Pharmaceuticals'(VRTX_) Kalydeco for cystic fibrosis April 24: Cell Therapeutics'(CTIC_) pixantrone for non-Hodgkin's lymphoma April 26: Amgen's(AMGN_) Xgeva for prevention or delay of spread of prostate cancer to bone. April 27: Vivus'(VVUS) avanafil for erectile dysfunction Share This Post: What would you like to do? Message: Endorse | Bookmark | Report AbuseUser Lady_Renegade: Reward | Watch | Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.